Tag Archives: PAC-1
Cancer Drug Shows Promise in Pet Dogs and Humans
OMD this is such exciting news! Thanks to a new $2 million investment, a drug that spurs cancer cells to self-destruct, while sparing healthy cells, is on the road to human clinical trials. The compound, known as PAC-1, is still … Continue reading
Posted in Zoey Says Stick It To Canine Cancer
Tagged canine cancer, canine lymphoma, canine osteosarcoma, clinical trials, PAC-1, University of Illinois
Comments Off on Cancer Drug Shows Promise in Pet Dogs and Humans